drugset / Trial / NCT04376593
PET/CT Imaging in COVID-19 Patients
NaSingle-groupOpen-labelDiagnostic
Summary
This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.
Timeline
- Start
- 2020-05-01
- Primary completion
- 2026-02-23
- Completion
- 2026-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-αvβ6-BP | Diagnostic / imaging agent | 370 mbq | Intravenous |